Business
PTC Therapeutics to Participate at Upcoming Virtual Investor Conferences
SOUTH PLAINFIELD, N.J., Aug. 27, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at
About this update from Ptc Therapeutics, Inc.
[{"type":"text","content":"SOUTH PLAINFIELD, N.J., Aug. 27, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company overview at the following conferences:\nMorgan Stanley Virtual 19th Annual Global Healthcare Conference Friday, September 10th at 11:00 a.m. ET\n2021 Cantor Virtual Global Healthcare Conference Monday, September 27th at 3:30 p.m. ET \nThe presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. \nAbout PTC Therapeutics, Inc. PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders.\nFOR MORE INFORMATION PLEASE CONTACT:\nMedia: \nInvestors:\nJane Baj \nKylie O'Keefe\n+1 (908) 912-9167 \n+1 (908) 300-0691\[email protected] \[email protected] \n View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-virtual-investor-conferences-301363921.html\nSOURCE PTC Therapeutics, Inc.","length":6812,"tagName":"div"}]